Australian Clinical Labs Ltd 2025 AR2
The report outlines the financial and operational performance of Australian Clinical Labs for the fiscal year ended June 30, 2025. The company achieved a total revenue of $741.3 million and an underlying EBIT of $68.0 million, representing an 8.7% increase from the previous year. Key sustainability achievements include reducing fleet travel by over 1 million kilometers, converting 47 additional vehicles to hybrids, and cutting packaging waste by 32,000 kilograms. Additionally, the company launched its Reflect Reconciliation Action Plan and achieved its board diversity target of 40:40:20.
Company: Australian Clinical Labs Ltd
Sector: Health Care
Country: Australia
Year: 2025
Type: AR2
Pages: 126
Australian Clinical Labs Ltd
The report outlines the financial and operational performance of Australian Clinical Labs for the fiscal year ended June 30, 2025. The company achieved a total revenue of $741.3 million and an underlying EBIT of $68.0 million, representing an 8.7% increase from the previous year. Key sustainability achievements include reducing fleet travel by over 1 million kilometers, converting 47 additional vehicles to hybrids, and cutting packaging waste by 32,000 kilograms. Additionally, the company launched its Reflect Reconciliation Action Plan and achieved its board diversity target of 40:40:20.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jul 1, 2024 - Jun 30, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees